{"disease":{"id":"idiopathic-gastroparesis","name":"idiopathic gastroparesis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04028492","title":"Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":992,"lead_sponsor_name":"Vanda Pharmaceuticals","has_results":false},{"nct_id":"NCT06899217","title":"A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":416,"lead_sponsor_name":"CinDome Pharma, Inc.","has_results":false},{"nct_id":"NCT03680859","title":"Gastroparesis Registry 3","phase":"","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT03544229","title":"A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04303195","title":"A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Neurogastrx, Inc.","has_results":true},{"nct_id":"NCT04661215","title":"Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT03268941","title":"A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03281577","title":"Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Takeda","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}